Eris Lifesciences Closes Velbiom Probiotics Acquisition

Eris Lifesciences announces successful closure of the Probiotics Business acquisition from Velbiom Probiotics Private Limited.
The transaction was initially intimated to exchanges on March 20, 2026, and achieved closure on March 31, 2026.
Filing was signed by Company Secretary Milind Talegaonkar and submitted to both BSE (540596) and NSE (ERIS).